Reeves DB - Search Results

1

Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence.

Reeves DB, Bacchus-Souffan C, Fitch M, Abdel-Mohsen M, Hoh R, Ahn H, Stone M, Hecht F, Martin J, Deeks SG, Hellerstein MK, McCune JM, Schiffer JT, Hunt PW. Reeves DB, et al. Nat Commun. 2023 Oct 2;14(1):6145. doi: 10.1038/s41467-023-41521-1. Nat Commun. 2023. PMID: 37783718 Free PMC article.

2

Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.

Reeves DB, Peterson CW, Kiem HP, Schiffer JT. Reeves DB, et al. J Virol. 2017 Jun 9;91(13):e00095-17. doi: 10.1128/JVI.00095-17. Print 2017 Jul 1. J Virol. 2017. PMID: 28404854 Free PMC article.

3

Anti-proliferative therapy for HIV cure: a compound interest approach.

Reeves DB, Duke ER, Hughes SM, Prlic M, Hladik F, Schiffer JT. Reeves DB, et al. Sci Rep. 2017 Jun 21;7(1):4011. doi: 10.1038/s41598-017-04160-3. Sci Rep. 2017. PMID: 28638104 Free PMC article.

4

Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.

Johnston C, Magaret A, Roychoudhury P, Greninger AL, Reeves D, Schiffer J, Jerome KR, Sather C, Diem K, Lingappa JR, Celum C, Koelle DM, Wald A. Johnston C, et al. PLoS Med. 2017 Dec 27;14(12):e1002475. doi: 10.1371/journal.pmed.1002475. eCollection 2017 Dec. PLoS Med. 2017. PMID: 29281620 Free PMC article.

5

Model-based estimation of superinfection prevalence from limited datasets.

Reeves DB, Magaret AS, Greninger AL, Johnston C, Schiffer JT. Reeves DB, et al. J R Soc Interface. 2018 Feb;15(139):20170968. doi: 10.1098/rsif.2017.0968. J R Soc Interface. 2018. PMID: 29491180 Free PMC article.

6

Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials.

Huang Y, Karuna S, Carpp LN, Reeves D, Pegu A, Seaton K, Mayer K, Schiffer J, Mascola J, Gilbert PB. Huang Y, et al. Hum Vaccin Immunother. 2018;14(9):2116-2127. doi: 10.1080/21645515.2018.1462640. Epub 2018 May 24. Hum Vaccin Immunother. 2018. PMID: 29683765 Free PMC article. Clinical Trial.

7

Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.

Roychoudhury P, De Silva Feelixge H, Reeves D, Mayer BT, Stone D, Schiffer JT, Jerome KR. Roychoudhury P, et al. BMC Biol. 2018 Jul 11;16(1):75. doi: 10.1186/s12915-018-0544-1. BMC Biol. 2018. PMID: 29996827 Free PMC article.

8

A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation.

Reeves DB, Duke ER, Wagner TA, Palmer SE, Spivak AM, Schiffer JT. Reeves DB, et al. Nat Commun. 2018 Nov 16;9(1):4811. doi: 10.1038/s41467-018-06843-5. Nat Commun. 2018. PMID: 30446650 Free PMC article.

9

Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women.

Pankau MD, Reeves DB, Harkins E, Ronen K, Jaoko W, Mandaliya K, Graham SM, McClelland RS, Matsen Iv FA, Schiffer JT, Overbaugh J, Lehman DA. Pankau MD, et al. Among authors: reeves db. PLoS Pathog. 2020 Feb 5;16(2):e1008286. doi: 10.1371/journal.ppat.1008286. eCollection 2020 Feb. PLoS Pathog. 2020. PMID: 32023326 Free PMC article. Clinical Trial.

10

Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.

Reeves DB, Huang Y, Duke ER, Mayer BT, Cardozo-Ojeda EF, Boshier FA, Swan DA, Rolland M, Robb ML, Mascola JR, Cohen MS, Corey L, Gilbert PB, Schiffer JT. Reeves DB, et al. PLoS Comput Biol. 2020 Feb 21;16(2):e1007626. doi: 10.1371/journal.pcbi.1007626. eCollection 2020 Feb. PLoS Comput Biol. 2020. PMID: 32084132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters